Search

Your search keyword '"Charreau B"' showing total 205 results
Start Over Author "Charreau B"
205 results on '"Charreau B"'

2. Bortezomib, C1-Inhibitor and Plasma Exchange Do Not Prolong the Survival of Multi-Transgenic GalT-KO Pig Kidney Xenografts in Baboons

Author

Le Bas-Bernardet, S., Tillou, X., Branchereau, J., Dilek, N., Poirier, N., Châtelais, M., Charreau, B., Minault, D., Hervouet, J., Renaudin, K., Crossan, C., Scobie, L., Takeuchi, Y., Diswall, M., Breimer, M.E., Klar, N., Daha, M.R., Simioni, P., Robson, S.C., Nottle, M.B., Salvaris, E.J., Cowan, P.J., d’Apice, A.J.F., Sachs, D.H., Yamada, K., Lagutina, I., Duchi, R., Perota, A., Lazzari, G., Galli, C., Cozzi, E., Soulillou, J.-P., Vanhove, B., and Blancho, G.

Published
2015
Full Text
View/download PDF

15. Production and characterization of GAL-/- minipigs over-expressing hCD55

Author

Brunetti D., Perota A., Lagutina I. Chatelais M., Charreau B., Duchi R., Lucchini F., LAZZARI, GIOVANNA, GALLI, CESARE, Brunetti D., Perota A., Lagutina I. Chatelais M., Charreau B., Duchi R., Lazzari G., Lucchini F., and Galli C.

Subjects
GAL-/- minipigs, hCD55
Published
2010

25. Production and characterization of Gal-/- minipigs over-expressing hCD55

Author

Brunetti, D, Perota, A, Lagutina, I, Chatelais, M, Charreau, B, Duchi, R, Lazzari, G, Lucchini, Franco, Galli, C., Lucchini, Franco (ORCID:0000-0003-0280-7062), Brunetti, D, Perota, A, Lagutina, I, Chatelais, M, Charreau, B, Duchi, R, Lazzari, G, Lucchini, Franco, Galli, C., and Lucchini, Franco (ORCID:0000-0003-0280-7062)

Published
2010

26. Analysis of transgene expression in transfected somatic pig cell to be used as donor in nuclear transfer

Author

Perota, A, Brunetti, D, Charreau, B, Chatelais, M, Lagutina, I, Lazzari, G, Lucchini, Franco, Galli, Cesare, Lucchini, Franco (ORCID:0000-0003-0280-7062), Perota, A, Brunetti, D, Charreau, B, Chatelais, M, Lagutina, I, Lazzari, G, Lucchini, Franco, Galli, Cesare, and Lucchini, Franco (ORCID:0000-0003-0280-7062)

Abstract

Background: Somatic cell nuclear transfer is the method of choice to generate transgenic large animals. Success largely depends on a high expression level of the target protein. Selection of cell clones with the desired expression level is of paramount importance before nuclear transfer. In this work we compare different methods that can be used on a small number of cells and their predictive value. Methods: Two expression vectors for CD55 and CD39 were separately transfected to PK15 cell line. Following selection, five of the best growing clones resulting from each transfection were expanded and subjected to RT-PCR and Immunohistochemistry (IHC) analyses. For IHC analyses the mAB IA10 (BD-Pharmingen) – for CD55 – and the mAB BU61 (Ancell) – for CD39 – were used. The same antibodies were also used in Western blot (WB) analyses performed on samples subjected to non-reducing SDS–PAGE and electroblotted on PVDF membrane. The presence of the target transcripts was confirmed by Northern blot (NB) analyses using DIGlabeled probes (Roche). The proteins expression was also analysed by FACS conducted on chosen clones. Fibroblasts and PAECs deriving from one CD55–CD39 stillborn cloned piglet were subjected to IHC, NB and FACS analyses. Results: Three out of five (#24, #2 and #15) PK15–CD55 clones were positive to RT-PCR but only clone #24 was positive to IHC. Clone #24 was further analysed by NB, WB and FACS that confirmed the high expression level. Clone #2 revealed a low expression level by FACS not detected by IHC. All five PK15–CD39 clones were positive to IHC and RT-PCR analysis. Clone #10 was further analysed and confirmed positive by NB and WB. The IHC, NB and FACS data obtained on fibroblasts and PAECs of cloned piglet confirmed the donor cell lines CD39 expression detected by IHC. This was not the case with CD55 expression since the positivity detected by IHC was not confirmed with FACS and NB analyses. Conclusion: IHC is the method of choice when few cells for each

Published
2009

27. Double transgenic Gal(-/-) piglets over-expressing hCD39

Author

Brunetti, D, Perota, A, Lagutina, I, Chatelais, M, Charreau, B, Duchi, R, Cozzi, E, Lazzari, G, Lucchini, Franco, Anegon, I, Sachs, Dh, Galli, Cesare, Lucchini, Franco (ORCID:0000-0003-0280-7062), Brunetti, D, Perota, A, Lagutina, I, Chatelais, M, Charreau, B, Duchi, R, Cozzi, E, Lazzari, G, Lucchini, Franco, Anegon, I, Sachs, Dh, Galli, Cesare, and Lucchini, Franco (ORCID:0000-0003-0280-7062)

Abstract

Over-expression of human CD39 in transgenic pigs is a potential strategy to bypass acute vascular rejection in xenotransplantation. The aim of this work is the production of transgenic cloned pigs using a Gal -/- CD55/CD39 cell line. A neonatal pig Gal -/- fibroblast line cultured in DMEM/M199 1:1 + 10% FCS + 5 ng/ml bFGF was co-transfected by nucleofection with two ubiquitous expression vectors, the first carrying hCD55 under Elongation Factor promoter and a HygroR cassette; the second carrying hCD39 under pCAGGS promoter and a 3¢ MAR region. After nucleofection, cells were plated in Petri dishes and selected with Hygromycin B for 8 days. Drug resistant colonies were isolated and expanded for transgene expression analysis. We used immunohistochemistry (IHC) to detect the expression of the proteins. For hCD55 we used IA10 and for hCD39 BU61. Cells co-expressing CD55–CD39 were serum starved for 24 h before being fused to enucleated oocytes. Following electric activation, embryos were grown in vitro up to compact morula/blastocyst and all (n=144) were transplanted in two synchronized sows. PAEC and fibroblasts derived from delivered piglets were analysed with FACS, using the following antibodies: BRIC110, IH4, 2G2, and MEM-118 for hCD55 and TU66 for hCD39 detection respectively. Using a double transgenic CD55/CD39 Gal -/- colony in a Somatic Cell Nuclear Transfer (SCNT) experiment we have obtained 35.4% compacted morula/blastocyst development. One of two sows resulted in a pregnancy. At day 117 of gestation, this sow was induced to farrowing and delivered two stillborn piglets that were probably too immature and died from respiratory failure. Nevertheless, IHC analysis performed on PAEC and fibroblasts derived from these piglets showed strong expression of CD55– CD39, as in the original colony. FACS analysis confirmed robust human CD39 expression but showed a very low level of hCD55 expression. Two Gal -/- CD55/CD39 piglets were obtained. Over-expression of hCD39 seem

Published
2009

33. Transplantation basic

Author

Cantaluppi, V., primary, De Lena, M., additional, Figliolini, F., additional, Beltramo, S., additional, Medica, D., additional, Tognarelli, G., additional, Biancone, L., additional, Tetta, C., additional, Segoloni, G. P., additional, Camussi, G., additional, Pontrelli, P., additional, Cariello, M., additional, Verrienti, R., additional, Tataranni, T., additional, Gigante, M., additional, Loverre, A., additional, Stallone, G., additional, Schena, F. P., additional, Ranieri, E., additional, Gesualdo, L., additional, Grandaliano, G., additional, Coupel, S., additional, Charreau, B., additional, Canet, E., additional, Gerard, N., additional, Segalen, I., additional, Alexandre, N., additional, Grall, A., additional, Jacques-Olivier, P., additional, Hillion, S., additional, Le Meur, Y., additional, Alexandre, H., additional, Dany, A., additional, Michel, D., additional, Denis, G., additional, Christophe, L., additional, Nacera, O., additional, Isabelle, B., additional, Eric, R., additional, Yi Chun, D. X., additional, Buob, D., additional, Grimbert, P., additional, Glowacki, F., additional, Labalette, M., additional, Dufosse, F., additional, Nochy, D., additional, Copin, M.-C., additional, Boleslawski, E., additional, Noel, C., additional, and Hazzan, M., additional

Published
2012
Full Text
View/download PDF

50. Early rise in circulating endothelial protein C receptor correlates with poor outcome in severe sepsis.

Author

Guitton C, Gérard N, Sébille V, Bretonnière C, Zambon O, Villers D, Charreau B, Guitton, Christophe, Gérard, Nathalie, Sébille, Véronique, Bretonnière, Cédric, Zambon, Olivier, Villers, Daniel, and Charreau, Béatrice

Abstract

Purpose: The endothelial protein C receptor (EPCR) negatively regulates the coagulopathy and inflammatory response in sepsis. Mechanisms controlling the expression of cell-bound and circulating soluble EPCR (sEPCR) are still unclear. Moreover, the clinical impact of EPCR shedding and its potential value to predict sepsis progression and outcome remain to be established.Methods: We investigated the time course of plasma sEPCR over the 5 first days (D) of severe sepsis in 40 patients.Results: No significant difference was observed when comparing sEPCR at admission (D1) to healthy volunteers and to patients with vasculitis. We report that the kinetics profile of plasma sEPCR in patients was almost stable at the onset of sepsis with no change from D1 to D4 and then a significant decrease at D5. This pattern of release was consistently observed whatever the level of sEPCR at D1. Characteristics of patients or of infections (except Gram negative) had no or little critical influence on the sEPCR profile. However, we found that sEPCR kinetics was clearly associated with patient's outcome (D28 survival). We demonstrate that a significant but moderate (<15% of basal level) and transient increase in sEPCR level at D2 is associated with poor outcome at D28.Conclusion: Severe sepsis, at the onset, only triggers moderate quantitative changes in plasma sEPCR levels. Our findings suggest that in severe sepsis, an early (at D2), transient but significant increase in circulating sEPCR may be detrimental suggesting that sEPCR could provide an early biological marker of sepsis outcome. [ABSTRACT FROM AUTHOR]

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results